{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:10:40Z","timestamp":1794265840502,"version":"4.9.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Consultancy Service for Enhancing Laboratory Surveillance of Emerging Infectious Diseases of the Department of Health, Hong Kong Special Administrative Region"},{"name":"Emerging Arbovirus Research"},{"name":"Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the Ministry of Education of China"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.antiviral.2017.02.002","type":"journal-article","created":{"date-parts":[[2017,2,7]],"date-time":"2017-02-07T00:17:51Z","timestamp":1486426671000},"page":"29-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":113,"special_numbering":"C","title":["Novel antiviral activity and mechanism of bromocriptine as a Zika virus NS2B-NS3 protease inhibitor"],"prefix":"10.1016","volume":"141","author":[{"given":"Jasper Fuk-Woo","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenn Ka-Heng","family":"Chik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuofeng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril Chik-Yan","family":"Yip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kah-Meng","family":"Tee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica Oi-Ling","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris Chung-Sing","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent Kwok-Man","family":"Poon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Jinxia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kin-Kui","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwok-Hung","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard Yi-Tsun","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwok-Yung","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2017.02.002_bib1","doi-asserted-by":"crossref","first-page":"925","DOI":"10.3201\/eid2205.151934","article-title":"Fatal sickle cell disease and Zika virus infection in girl from Colombia","volume":"22","author":"Arzuza-Ortega","year":"2016","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2017.02.002_bib2","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jcv.2016.10.024","article-title":"Zika virus epidemic in Brazil. I. Fatal disease in adults: clinical and laboratorial aspects","volume":"85","author":"Azevedo","year":"2016","journal-title":"J.\u00a0Clin. Virol."},{"key":"10.1016\/j.antiviral.2017.02.002_bib3","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.chom.2016.07.004","article-title":"A\u00a0screen of FDA-approved drugs for inhibitors of Zika virus infection","volume":"20","author":"Barrows","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.antiviral.2017.02.002_bib4","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.antiviral.2016.11.023","article-title":"The FDA-approved drug sofosbuvir inhibits Zika virus infection","volume":"137","author":"Bullard-Feibelman","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2017.02.002_bib5","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0140-6736(16)00562-6","article-title":"Guillain-Barre Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study","volume":"387","author":"Cao-Lormeau","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2017.02.002_bib6","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1056\/NEJMc1602964","article-title":"Zika virus associated with meningoencephalitis","volume":"374","author":"Carteaux","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.antiviral.2017.02.002_bib7","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1146\/annurev.mi.44.100190.003245","article-title":"Flavivirus genome organization, expression, and replication","volume":"44","author":"Chambers","year":"1990","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.antiviral.2017.02.002_bib8","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jinf.2013.09.029","article-title":"Broad-spectrum antivirals for the emerging middle east respiratory syndrome coronavirus","volume":"67","author":"Chan","year":"2013","journal-title":"J.\u00a0Infect."},{"key":"10.1016\/j.antiviral.2017.02.002_bib9","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1093\/infdis\/jiv392","article-title":"Treatment with lopinavir\/ritonavir or interferon-beta1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset","volume":"212","author":"Chan","year":"2015","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2017.02.002_bib10","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.jinf.2016.02.011","article-title":"Zika fever and congenital Zika syndrome: an unexpected emerging arboviral disease","volume":"72","author":"Chan","year":"2016","journal-title":"J.\u00a0Infect."},{"key":"10.1016\/j.antiviral.2017.02.002_bib11","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1038\/emi.2016.99","article-title":"Differential cell line susceptibility to the emerging Zika virus: implications for disease pathogenesis, non-vector-borne human transmission and animal reservoirs","volume":"5","author":"Chan","year":"2016","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.antiviral.2017.02.002_bib12","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ebiom.2016.11.017","article-title":"Zika virus infection in dexamethasone-immunosuppressed mice demonstrating disseminated infection with multi-organ involvement including orchitis effectively treated by recombinant type I interferons","volume":"14","author":"Chan","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.antiviral.2017.02.002_bib13","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/cr.2016.116","article-title":"Mechanisms of activation and inhibition of Zika virus NS2B-NS3 protease","volume":"26","author":"Chen","year":"2016","journal-title":"Cell Res."},{"key":"10.1016\/j.antiviral.2017.02.002_bib14","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.antiviral.2013.08.016","article-title":"Clinical management and infection control of SARS: lessons learned","volume":"100","author":"Cheng","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2017.02.002_bib15","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jcv.2016.08.299","article-title":"Two cases of thrombocytopenic purpura at onset of Zika virus infection","volume":"83","author":"Chraibi","year":"2016","journal-title":"J.\u00a0Clin. Virol."},{"key":"10.1016\/j.antiviral.2017.02.002_bib16","article-title":"Zika virus infectious cell culture system and the in\u00a0vitro prophylactic effect of interferons","volume":"114","author":"Contreras","year":"2016","journal-title":"J.\u00a0Vis. Exp."},{"key":"10.1016\/j.antiviral.2017.02.002_bib17","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.chom.2016.04.013","article-title":"Structures of the Zika virus envelope protein and its complex with a flavivirus broadly protective antibody","volume":"19","author":"Dai","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.antiviral.2017.02.002_bib18","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.fertnstert.2004.09.024","article-title":"Evaluation of a novel vaginal bromocriptine mesylate formulation: a pilot study","volume":"83","author":"Darwish","year":"2005","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.antiviral.2017.02.002_bib19","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/j.fertnstert.2007.09.029","article-title":"Clinical efficacy of novel unidirectional buccoadhesive vs. vaginoadhesive bromocriptine mesylate discs for treating pathologic hyperprolactinemia","volume":"90","author":"Darwish","year":"2008","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.antiviral.2017.02.002_bib20","doi-asserted-by":"crossref","DOI":"10.1001\/jamaophthalmol.2016.0267","article-title":"Ocular findings in infants with microcephaly associated with presumed Zika virus congenital infection in salvador, Brazil","author":"de Paula Freitas","year":"2016","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.antiviral.2017.02.002_bib21","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/BF00635902","article-title":"Pharmacokinetics of a long-acting bromocriptine preparation (Parlodel LA) and its effect on release of prolactin and growth hormone","volume":"29","author":"del Pozo","year":"1986","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.antiviral.2017.02.002_bib22","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1128\/AAC.48.10.3702-3710.2004","article-title":"Combinations of adefovir with nucleoside analogs produce additive antiviral effects against hepatitis B virus in\u00a0vitro","volume":"48","author":"Delaney","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2017.02.002_bib23","article-title":"Chloroquine inhibits Zika Virus infection in different cellular models","author":"Delvecchio","year":"2016","journal-title":"bioRxiv"},{"key":"10.1016\/j.antiviral.2017.02.002_bib24","doi-asserted-by":"crossref","first-page":"ofw175","DOI":"10.1093\/ofid\/ofw175","article-title":"Adenosine analog NITD008 is a potent inhibitor of Zika virus","volume":"3","author":"Deng","year":"2016","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.antiviral.2017.02.002_bib25","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1056\/NEJMoa0805715","article-title":"Zika virus outbreak on Yap island, Federated States of Micronesia","volume":"360","author":"Duffy","year":"2009","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.antiviral.2017.02.002_bib26","first-page":"467","article-title":"Use of minocycline in viral infections","volume":"133","author":"Dutta","year":"2011","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.antiviral.2017.02.002_bib27","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1002\/jmv.24678","article-title":"Zika viral polymerase inhibition using anti-HCV drugs both in market and under clinical trials","volume":"88","author":"Elfiky","year":"2016","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.antiviral.2017.02.002_bib28","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/infdis\/jiw226","article-title":"Nucleoside inhibitors of Zika virus","volume":"214","author":"Eyer","year":"2016","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2017.02.002_bib29","first-page":"461","article-title":"A\u00a0comparison of octreotide, bromocriptine, or a combination of both drugs in acromegaly","volume":"79","author":"Fl\u00f8gstad","year":"1994","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.antiviral.2017.02.002_bib30","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1093\/jac\/dku091","article-title":"The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entry","volume":"69","author":"Gehring","year":"2014","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2017.02.002_bib31","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1016\/j.theriogenology.2012.08.003","article-title":"Role of LH in the progesterone increase during the bromocriptine-induced prolactin decrease in heifers","volume":"78","author":"Ginther","year":"2012","journal-title":"Theriogenology"},{"key":"10.1016\/j.antiviral.2017.02.002_bib32","doi-asserted-by":"crossref","first-page":"8880","DOI":"10.1128\/JVI.00354-15","article-title":"Biology of Zika virus infection in human skin cells","volume":"89","author":"Hamel","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.02.002_bib33","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.pharmthera.2013.12.001","article-title":"Artemisinins: pharmacological actions beyond anti-malarial","volume":"142","author":"Ho","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.antiviral.2017.02.002_bib34","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1099\/0022-1317-4-2-203","article-title":"Comparison of the antiviral activity in\u00a0vitro of some non-steroidal anti-inflammatory drugs","volume":"4","author":"Inglot","year":"1969","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.antiviral.2017.02.002_bib35","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.antiviral.2016.11.003","article-title":"Efficacy of the broad-spectrum antiviral compound BCX4430 against Zika virus in cell culture and in a mouse model","volume":"137","author":"Julander","year":"2016","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2017.02.002_bib36","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.antiviral.2016.04.014","article-title":"Novel antiviral activity of bromocriptine against dengue virus replication","volume":"131","author":"Kato","year":"2016","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2017.02.002_bib37","doi-asserted-by":"crossref","first-page":"917","DOI":"10.15585\/mmwr.mm6534e3","article-title":"Hearing loss in infants with microcephaly and evidence of congenital Zika virus infection - Brazil, november 2015-may 2016","volume":"65","author":"Leal","year":"2016","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.antiviral.2017.02.002_bib38","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1126\/science.aag2419","article-title":"Crystal structure of Zika virus NS2B-NS3 protease in complex with a boronate inhibitor","volume":"353","author":"Lei","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2017.02.002_bib39","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0140-6736(16)00644-9","article-title":"Acute myelitis due to Zika virus infection","volume":"387","author":"Mecharles","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2017.02.002_bib40","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1056\/NEJMoa1600651","article-title":"Zika virus associated with microcephaly","volume":"374","author":"Mlakar","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.antiviral.2017.02.002_bib41","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1128\/CMR.00072-15","article-title":"Zika virus","volume":"29","author":"Musso","year":"2016","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.antiviral.2017.02.002_bib42","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0014-2999(98)00896-6","article-title":"Functional potencies of new antiparkinsonian drugs at recombinant human dopamine D1, D2 and D3 receptors","volume":"366","author":"Perachon","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.antiviral.2017.02.002_bib43","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2013a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.antiviral.2017.02.002_bib44","doi-asserted-by":"crossref","first-page":"13410","DOI":"10.1038\/ncomms13410","article-title":"Structure of the NS2B-NS3 protease from Zika virus after self-cleavage","volume":"7","author":"Phoo","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2017.02.002_bib45","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/BF03347120","article-title":"Evaluation of a repeatable depot-bromocriptine preparation(Parlodel LAR) for the treatment of acromegaly","volume":"14","author":"Plockinger","year":"1991","journal-title":"J.\u00a0Endocrinol. Invest."},{"key":"10.1016\/j.antiviral.2017.02.002_bib46","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1128\/AAC.00189-09","article-title":"Cyclosporine inhibits flavivirus replication through blocking the interaction between host cyclophilins and viral NS5 protein","volume":"53","author":"Qing","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2017.02.002_bib47","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/jmv.1890410203","article-title":"Hepatitis C viral RNA titers in serum prior to, during, and after oral treatment with ribavirin for chronic hepatitis C","volume":"41","author":"Reichard","year":"1993","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.antiviral.2017.02.002_bib48","doi-asserted-by":"crossref","first-page":"14408","DOI":"10.1073\/pnas.1618029113","volume":"113","author":"Retallack","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2017.02.002_bib49","doi-asserted-by":"crossref","first-page":"104","DOI":"10.5808\/GI.2016.14.3.104","article-title":"Virtual screening for potential inhibitors of NS3 protein of Zika virus","volume":"14","author":"Sahoo","year":"2016","journal-title":"Genomics Inf."},{"key":"10.1016\/j.antiviral.2017.02.002_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/nature20564","article-title":"Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice","author":"Sapparapu","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2017.02.002_bib51","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S1473-3099(16)30006-8","article-title":"Zika virus associated deaths in Colombia","volume":"16","author":"Sarmiento-Ospina","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.antiviral.2017.02.002_bib52","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jcv.2016.08.297","article-title":"Fatal encephalitis associated with Zika virus infection in an adult","volume":"83","author":"Soares","year":"2016","journal-title":"J.\u00a0Clin. Virol."},{"issue":"11","key":"10.1016\/j.antiviral.2017.02.002_bib53","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1177\/1947601912440575","article-title":"Quantitative methods for assessing drug synergism","volume":"2","author":"Tallarida","year":"2011","journal-title":"Genes Cancer"},{"key":"10.1016\/j.antiviral.2017.02.002_bib54","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1177\/1352458516634872","article-title":"Interferon-beta exposure during first trimester is safe in women with multiple sclerosis-a prospective cohort study from the German multiple sclerosis and pregnancy registry","volume":"22","author":"Thiel","year":"2016","journal-title":"Mult. Scler."},{"key":"10.1016\/j.antiviral.2017.02.002_bib55","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.antiviral.2017.02.002_bib56","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1128\/AAC.00620-11","article-title":"A\u00a0translation inhibitor that suppresses dengue virus in\u00a0vitro and in\u00a0vivo","volume":"55","author":"Wang","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2017.02.002_bib57","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nm.4184","article-title":"Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen","volume":"22","author":"Xu","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2017.02.002_bib58","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0026-0495(99)90202-0","article-title":"Bromocriptine\/SKF38393 treatment ameliorates dyslipidemia in ob\/ob mice","volume":"48","author":"Zhang","year":"1999","journal-title":"Metabolism"},{"key":"10.1016\/j.antiviral.2017.02.002_bib59","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1093\/infdis\/jit504","article-title":"Active replication of middle east respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis","volume":"209","author":"Zhou","year":"2014","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2017.02.002_bib60","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1038\/emi.2016.48","article-title":"Comparative genomic analysis of pre-epidemic and epidemic Zika virus strains for virological factors potentially associated with the rapidly expanding epidemic","volume":"5","author":"Zhu","year":"2016","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.antiviral.2017.02.002_bib61","doi-asserted-by":"crossref","first-page":"e0004695","DOI":"10.1371\/journal.pntd.0004695","article-title":"The viral polymerase inhibitor 7-deaza-2'-C-methyladenosine is a potent inhibitor of in\u00a0vitro Zika virus replication and delays disease progression in a robust mouse infection model","volume":"10","author":"Zmurko","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.antiviral.2017.02.002_bib62","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrd.2015.37","article-title":"Coronaviruses - drug discovery and therapeutic options","volume":"15","author":"Zumla","year":"2016","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216307252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216307252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T05:47:14Z","timestamp":1719035234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354216307252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":62,"alternative-id":["S0166354216307252"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2017.02.002","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel antiviral activity and mechanism of bromocriptine as a Zika virus NS2B-NS3 protease inhibitor","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2017.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}